200 related articles for article (PubMed ID: 12722377)
1. [The results of screening program for cervical cancer in Lodz].
Gottwald L; Giernat L; Lech W; Wójcik-Krowiranda K; Akoel KM; Kowalczyk-Amico K; Estemberg D; Grzesiak M; Sosnowski D; Guzowski G; Baś E; Tyliński W; Bieńkiewicz A
Ginekol Pol; 2002 Nov; 73(11):934-8. PubMed ID: 12722377
[TBL] [Abstract][Full Text] [Related]
2. [Estimated results of prophylactic physical examinations detecting cervical cancer in Center of Oncology in Bydgoszcz in years 2001-2003].
Mierzwa T; Grabiec M; Walentowicz M
Ginekol Pol; 2005 Sep; 76(9):693-8. PubMed ID: 16417080
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic medical investigations for breast cancer and uterine cervix cancer in Regional Oncology Centre of Bydgoszcz in 2003].
Mierzwa T; Grabiec M
Wiad Lek; 2004; 57 Suppl 1():207-10. PubMed ID: 15884240
[TBL] [Abstract][Full Text] [Related]
4. [Prophylactic medical examinations for breast cancer and uterine cervix cancer in Regional Oncological Center of Bydgoszcz in year 2002].
Mierzwa T; Siwek P; Grabiec M
Ginekol Pol; 2003 Sep; 74(9):811-6. PubMed ID: 14674129
[TBL] [Abstract][Full Text] [Related]
5. [Cervical cancer screening in Poland and worldwide].
Spaczyński M; Nowak-Markwitz E; Kedzia W
Ginekol Pol; 2007 May; 78(5):354-60. PubMed ID: 17867325
[TBL] [Abstract][Full Text] [Related]
6. [Comparative analysis of abnormal Pap smear and the results of histopathological examination of specimens from the cervix of the programme in-depth diagnosis cervical cancer conducted at the of Operational Gynecology Department ICZMP in Lodz].
Kulig B; Łukaszek S; Brucka A; Kałuzyński A; Kamer-Bartosińska A; Szyłło K
Ginekol Pol; 2010 Nov; 81(11):828-33. PubMed ID: 21365898
[TBL] [Abstract][Full Text] [Related]
7. [Verification of doubtful PAP smear results of women included in the screening program in the Podlaskie province].
Błońska E; Knapp PA
Ginekol Pol; 2013 Aug; 84(8):691-5. PubMed ID: 24191502
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program.
Thipsanthiah K; Kamsa-Ard S; Musika W; Teemuangsai W; Hawlader MDH
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3429-3436. PubMed ID: 37898847
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of abnormal Papanicolaou smears in female sex workers in Hong Kong.
Leung KM; Yeoh GP; Cheung HN; Fong FY; Chan KW
Hong Kong Med J; 2013 Jun; 19(3):203-6. PubMed ID: 23650200
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency of abnormal Papanicolaou smears in adolescents.
Silva CS; Souza MA; Angelo AG; Pavani R; Adad SJ; Murta EF
Arch Gynecol Obstet; 2002 Jul; 266(3):154-6. PubMed ID: 12197555
[TBL] [Abstract][Full Text] [Related]
12. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
Lertcharernrit J; Sananpanichkul P; Suknikhom W; Bhamarapravatana K; Suwannarurk K; Leaungsomnapa Y
Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
[TBL] [Abstract][Full Text] [Related]
15. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of the Papanicolaou test in the detection of high-grade cervical lesions.
Repše-Fokter A
Int J Gynaecol Obstet; 2011 Jan; 112(1):65-6. PubMed ID: 21056413
[No Abstract] [Full Text] [Related]
17. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
Strander B; Andersson-Ellström A; Milsom I; Rådberg T; Ryd W
Cancer; 2007 Oct; 111(5):285-91. PubMed ID: 17724676
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of epithelial cell abnormalities of uterine cervix in a cervical cancer screening programme: implications for resource limited settings.
Gupta S; Sodhani P; Halder K; Chachra KL; Sardana S; Singh V; Sehgal A
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):238-42. PubMed ID: 16920248
[TBL] [Abstract][Full Text] [Related]
19. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
20. [Cervical cancer screening by Pap smear: experience of the National Research Center in Reproductive Health. ONFP].
Ben Aissa R; Bennour R; Ben Hamida A; Kammoun N; Mansour H; Mhamdi A; Landoulsi S; Cherif N; Gueddana N
Tunis Med; 2002 Apr; 80(4):203-6. PubMed ID: 12416356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
